Shares outstanding increased 34.5%
Shares outstanding changed +34.5% from the comparable as-filed period. The change ranks at the 86th percentile of 7 prior comparable changes.
62,018,135→83,408,0507 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PYXS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current assets decreased 63.2%
Current assets changed -63.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$100.0M→$36.7M4 prior comparisons
Current liabilities increased 55.4%
Current liabilities changed +55.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$17.7M→$27.5M4 prior comparisons
Current ratio decreased 76.4%
Current ratio changed -76.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
5.65→1.344 prior comparisons
Total assets decreased 55.4%
Total assets changed -55.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$123.2M→$54.9M4 prior comparisons
Working capital / assets moved 4992 bp lower
Working capital / assets changed -4992 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
66.78%→16.86%4 prior comparisons
Working capital decreased 88.7%
Working capital changed -88.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$82.3M→$9.3M4 prior comparisons
Operating income decreased 31.6%
Operating income changed -31.6% from the comparable as-filed period.
-$19.8M→-$26.0M3 prior comparisons
Stock-based compensation increased 83.3%
Stock-based compensation changed +83.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$3.0M→$5.5M3 prior comparisons
Cash & equivalents increased 75.7%
Cash & equivalents changed +75.7% from the comparable as-filed period.
$10.7M→$18.9M3 prior comparisons
Operating cash flow decreased 5.5%
Operating cash flow changed -5.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$17.3M→-$18.2M4 prior comparisons
Research & development decreased 6.3%
Research & development changed -6.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$17.1M→$16.1M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.